miR-21 and mi-R1246 |
Significantly high in BC although ubiquitous in human exosomes |
Hannafon et al. [78] |
miR-145, miR-155 and miR-382 |
Significantly high in BC although ubiquitous in human exosomes |
Gonzalez-Villasana et al. [83] |
miR-101 and miR-372 |
Significantly high in BC |
Eichelser et al. [84] |
miR-223-3p |
Significantly high in BC |
Yoshikawa et al. [85] |
miR-16 |
Significantly high in BC, especially if estrogen-positive |
Ni et al. [86] |
miR-93 |
Significantly high in DCIS |
Ni et al. [86] |
miR-188-3p, miR-500a-5p and miR-502-3p (miR-532-502 cluster) |
Significantly high in BC |
Zou et al. [87] |
miR-122-5p |
Significantly high in BC |
Li et al. [88] |
miR-106a-3p, miR-106a-5p, miR-92a-2-5p, miR-19b-3p and miR-92a-3p (miR-106a-363 cluster) |
Significantly high in BC |
Li et al. [89] |
let-7b-5p, miR-106a-5p, miR-19a-3p, miR-19b-3p, miR-25-3p, miR-425-5p, miR-451a, miR-92a-3p, miR-93-5p and miR-16-5p |
Significantly high in BC |
Zou et al. [90] |
miR-148a |
Significantly downregulated in BC |
Li et al. [92] |
miR-27a/b, miR-30c, miR-150, miR-152, miR-199a-3p, miR-340, miR-376a, miR-410 and miR-598 |
Significantly deregulated in BC |
Stevic et al. [96] |
miR-21 and miR-105 |
Significantly high in metastatic vs. localized BC |
Rodriguez-Martinez et al. [93] |
miR-373 |
Significantly high in TNBC |
Eichelser et al. [84] |
miR-222 |
Significantly high in TNBC and luminal B vs. luminal A BC |
Rodriguez-Martinez et al. [93] |
miR-27b, miR-30c, miR-128a, miR-145, miR-150, miR-152, miR-199a-3p, miR-324-3p, miR-335, miR-340, miR-376a/c, miR-382, miR-410, miR-423-5p, miR-433 and miR-598 |
Significantly deregulated in TNBC |
Stevic et al. [96] |
miR-27a/b, miR-30c, miR-150, miR-152, miR-199a-3p, miR-328, miR-340, miR-365, miR-410, miR-422a, miR-598 and miR-628 |
Significantly deregulated in HER2-positive BC |
Stevic et al. [96] |